1. Analyst View
2. Market Drivers
2.1 Macroeconomic & Demographic Profile
2.2 Product Patent Regime
2.3 Medical Infrastructure
2.4 Prevalence of Lifestyle-related Diseases
3. Indian Pharmaceutical Market
3.1 Market Overview
3.2 Domestic & Exports Market
3.3 Future Outlook
4. Branded & Generics
5. Market Segmentation by Type of Drugs
5.1 Bulk Drugs/APIs
5.2 Formulations
6. Therapeutics
6.1 Acute Segment
6.1.1 Anti-Infectives
6.1.2 Gastrointestinal
6.1.3 Vitamins/Minerals/Nutrients
6.1.4 Pain/Analgesics
6.1.5 Dermatology
6.1.6 Gynecology
6.1.7 Respiratory
6.2 Chronic Segment
6.2.1 Cardiac
6.2.2 Neuro/CNS
6.2.3 Anti-Diabetic
7. Distribution Channel Analysis of Indian Pharmaceutical Industry
8. Regulatory Overview
8.1 Industry Regulations
8.2 Government Initiatives
9. Emerging Sectors
9.1 Biogenerics
9.2 Pharma Outsourcing Market
9.3 Bioinformatics
9.4 Clinical Trials
9.5 Pharma Packaging Industry
10. Industry Restraints & RNCOS Reccomendations
10.1 Counterfeit Drugs
10.2 Drug Price Controls & Low Margins
10.3 Per Capita Spending on Drugs
10.4 Investments & R&D
11. Competitive Landscape
11.1 Market Structure
11.2 M&A’s & Industry Developments
11.3 Key Players Analysis
11.3.1 Ranbaxy Laboratories Limited
11.3.2 Cipla Limited
11.3.3 GlaxoSmithKline Pharmaceuticals Limited
11.3.4 Nicholas Piramal India Limited
11.3.5 Zydus Cadila
